EUDA Health Holdings Limited
NASDAQ:EUDAMedical - Care Facilities
+$2.20 today
- Market cap
- $53.00M
- Beta
- 0.59
- P/E (TTM)
- -7.9
- EPS (TTM)
- -$1.79
Volume 0.04M
Average 0.02M
EUDA Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
EUDA Health Holdings LimitedNASDAQ: EUDA
Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026
Change in working capital growth accelerates
Q2 FY2026 change in working capital of $316.54K (cash outflow) rose 97.1% year over year, ahead of the +41.8% change in trailing-twelve-month change in working capital. Sequentially, it rose 0.0% from the prior quarter.
Context
- Change in working capital amounted to 3.4% of revenue in FY2025, down 1.5 pp from a year earlier.
- Change in working capital increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +97.1% holds above the trailing-twelve-month pace of +41.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- (230.03K) USD
- Year-over-year change
- -218.0%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (230.03K) | -218.0% |
| FY2024 | 2024-12-31 | 194.93K | -63.3% |
| FY2023 | 2023-12-31 | 531.2K | -52.6% |
| FY2022 | 2022-12-31 | 1.12M | -5.0% |
| FY2021 | 2021-12-31 | 1.18M | — |
Change in Working Capital vs competitors
How EUDA compares with its peers on the latest reported figures
- Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +41.8% is the 4th highest of 8, against a peer median of -7.5%.
- Change in working capital amounts to 5.9% of revenue for EUDA, versus a peer median of 39.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $28.81M USD | -17.6% | — | 63.9% | |
| LTM Mar 2026 | $13.9M USD | +46.9% | -1.6% | 5.9% | |
| LTM Mar 2026 | $6.67M USD | -20.7% | -16.8% | 6.3% | |
| LTM Mar 2026 | $5.86M USD | +748.8% | — | 3083.7% | |
| LTM Mar 2026 | $2.99M USD | -169.9% | -31.7% | — | |
| LTM Mar 2026 | $2.24M USD | +130.2% | — | 14.6% | |
| LTM Mar 2026 | CA$1.15M CAD | -7.5% | — | 692.6% | |
| LTM Jun 2026 | $715.58K USD | +41.8% | — | 5.9% | |
| Peer median (excluding EUDA) | — | -7.5% | -16.8% | 39.2% | |
Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 900.4K | (24.95M) | (8.44M) | (17.6M) | (2.77M) |
| Depreciation & Amortization | 264.1K | 172.02K | 119.35K | 173.22K | 406.48K |
| Deferred Income Tax | (27.68K) | (48.23K) | 0 | (4.38K) | 4.38K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 1.18M | 1.12M | 531.2K | 194.93K | (230.03K) |
| Accounts Receivables | (263.95K) | (174.82K) | (32.97K) | 82.35K | (166.99K) |
| Inventory | 0 | 3.69M | 0 | (126.27K) | 45.43K |
| Accounts Payables | 1.38M | (1.13M) | 1.27K | 15.99K | (12.95K) |
| Other Working Capital | 68.04K | (1.27M) | 562.89K | 222.86K | (95.52K) |
| Other Non-Cash Items | (1.87M) | 22.18M | 4.87M | 15.21M | 160.35K |
| Operating Cash Flow | 443.92K | (1.53M) | (2.92M) | (2.03M) | (2.43M) |
| Capital Expenditures | (1.96K) | (18.14K) | (5) | (116.03K) | (104.45K) |
| Acquisitions (Net) | (354.23K) | (3.41K) | 0 | 16.3K | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (355.08K) | (246.66K) | 5 | (48.03K) | (27.19K) |
| Investing Cash Flow | (356.18K) | (268.21K) | 0 | (147.77K) | (104.45K) |
| Debt Repayment | (6.69K) | 1.4M | 1.44M | 2.16M | 2.22M |
| Common Stock Issued | 0 | 1.1M | 790K | 50K | 100K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (161.69K) | (9.47K) | 121.88K | 115.14K | 234.46K |
| Financing Cash Flow | (168.37K) | 2.49M | 2.35M | 2.32M | 2.55M |
| Effect of Forex Changes | 19.87K | (99.42K) | (21.53K) | (101.66K) | 88.49K |
| Net Change in Cash | (60.77K) | 594.49K | (586.93K) | 40.05K | 107.54K |
| Free Cash Flow | 441.96K | (1.54M) | (2.92M) | (2.15M) | (2.53M) |
EUDA Health Holdings Limited
NASDAQ:EUDA
Intrinsic Alpha fair value
Locked
Current Price
$17.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.